Power-PD: Empowering people with Parkinson’s Disease (PD) through flexible exercise

A hybrid delivery of exercise for physical self-management in people with Parkinson’s Disease – a single-arm feasibility study with pre and post-test design

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN17094208

Enrollment

Registered

2026-06-23

Start date

2026-08-01

Completion date

Unknown

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson’s Disease Nervous System Diseases

Interventions

Power-PD, Power-PD is a 12-week physical self-management intervention designed specifically for people with Parkinson's. It consists of Parkinson's-specific exercise and peer-supported discussions to

Eligibility

Sex/Gender

All

Age

18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Community-dwelling adults with a clinical diagnosis of idiopathic Parkinson's disease 2. Stable medication (if taking any) for >3/52 3. Able to mobilise independently with/without walking aid outdoors and independently without walking aid indoors (equivalent to Hoehn & Yahr (PD rating scale) I-III)

Exclusion criteria

Exclusion criteria: 1. Inability to participate in exercise e.g., due to physical, mental or cognitive co-morbidities e.g., heart or lung conditions, uncontrolled diabetes ,other neurological disorders, cancer or musculoskeletal conditions e.g., back pain or severe arthritis 2. Inability to consent or complete outcome measures 3. Severe, unpredictable motor fluctuations 4. Participated in an exercise and/or self-management intervention specifically for Parkinson's disease within the last 12 months

Design outcomes

Primary

Measure	Time frame
Acceptability measured using study specifically designed questionnaire, interviews, Participant demographic data at baseline, 12 weeks, 24 weeks;Feasibility measured using data on recruitment, adherence, engagement, completion rates, adverse events, and collection of health economic data at baseline, 12 weeks, 24 weeks;Fidelity measured using interviews, session observation, fidelity checklist at baseline, 12 weeks, 24 weeks	—

Measure

Time frame

Acceptability measured using study specifically designed questionnaire, interviews, Participant demographic data at baseline, 12 weeks, 24 weeks;Feasibility measured using data on recruitment, adherence, engagement, completion rates, adverse events, and collection of health economic data at baseline, 12 weeks, 24 weeks;Fidelity measured using interviews, session observation, fidelity checklist at baseline, 12 weeks, 24 weeks

—

Secondary

Measure	Time frame
1. Physical activity measured using International Physical Activity Questionnaire (IPAQ) – short form at baseline, 12 weeks, 24 weeks 2. Physical activity measured using Physical activity diary at baseline, 12 weeks, 24 weeks 3. Physical activity measured using GeneActiv Body worn Accelerometer at baseline, 12 weeks, 24 weeks 4. Parkinson's symptoms measured using Movement Disorders Society Universal Parkinson's Disease Rating Scale (MDS-UPDRS) with Schwab & England Scale at baseline, 12 weeks, 24 weeks 5. Physical function measured using Timed Up and Go (TUG) at baseline, 12 weeks, 24 weeks 6. Self-efficacy measured using Self-efficacy for exercise (SEE) questionnaire at baseline, 12 weeks, 24 weeks 7. Participant importance and confidence measured using Importance/Confidence visual analogue scale at baseline, 12 weeks, 24 weeks 8. Anxiety and depression measured using Hospital Anxiety and Depression Scale (HADS) at baseline, 12 weeks, 24 weeks 9. Quality of life measured using Patient-Reported Outcomes Measurement Information System (PROMIS) at baseline, 12 weeks, 24 weeks 10. Quality of life measured using EuroQol 5 domain 5 level (EQ-5D-5L) at baseline, 12 weeks, 24 weeks 11. Function and well-being measured using Parkinson's Disease Questionnaire-8 (PDQ-8) at baseline, 12 weeks, 24 weeks 12. Service utilisation measured using Client Service Receipt Inventory (CSRI) at baseline, 12 weeks, 24 weeks 13. Capability measured using ICEpop CAPability measure for Older people (ICECAP-O) at baseline, 12 weeks, 24 weeks	—

Measure

Time frame

1. Physical activity measured using International Physical Activity Questionnaire (IPAQ) – short form at baseline, 12 weeks, 24 weeks 2. Physical activity measured using Physical activity diary at baseline, 12 weeks, 24 weeks 3. Physical activity measured using GeneActiv Body worn Accelerometer at baseline, 12 weeks, 24 weeks 4. Parkinson's symptoms measured using Movement Disorders Society Universal Parkinson's Disease Rating Scale (MDS-UPDRS) with Schwab & England Scale at baseline, 12 weeks, 24 weeks 5. Physical function measured using Timed Up and Go (TUG) at baseline, 12 weeks, 24 weeks 6. Self-efficacy measured using Self-efficacy for exercise (SEE) questionnaire at baseline, 12 weeks, 24 weeks 7. Participant importance and confidence measured using Importance/Confidence visual analogue scale at baseline, 12 weeks, 24 weeks 8. Anxiety and depression measured using Hospital Anxiety and Depression Scale (HADS) at baseline, 12 weeks, 24 weeks 9. Quality of life measured using Patient-Reported Outcomes Measurement Information System (PROMIS) at baseline, 12 weeks, 24 weeks 10. Quality of life measured using EuroQol 5 domain 5 level (EQ-5D-5L) at baseline, 12 weeks, 24 weeks 11. Function and well-being measured using Parkinson's Disease Questionnaire-8 (PDQ-8) at baseline, 12 weeks, 24 weeks 12. Service utilisation measured using Client Service Receipt Inventory (CSRI) at baseline, 12 weeks, 24 weeks 13. Capability measured using ICEpop CAPability measure for Older people (ICECAP-O) at baseline, 12 weeks, 24 weeks

—

Countries

England, United Kingdom

Contacts

Public ContactJames Alexander

james.alexander@ucl.ac.uk+44 207 794055 ext.034374

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026